Harbourvest Partners LLC Axcella Health Inc. Transaction History

Harbourvest Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.16 - $1.1 $292,682 - $2.01 Million	1,829,268 Added 41.78%	6,207,929 $2.05 Million
Q1 2022 May 26, 2022	BUY	$1.58 - $2.82 $2.48 Million - $4.43 Million	1,570,680 Added 55.94%	4,378,661 $11.3 Million
Q2 2020 Aug 13, 2020	BUY	$2.94 - $7.7 $4.64 Million - $12.2 Million	1,578,947 Added 128.47%	2,807,981 $15.5 Million
Q2 2019 Sep 05, 2019	BUY	$8.51 - $14.95 $10.5 Million - $18.4 Million	1,229,034 New	1,229,034 $11.4 Million

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Harbourvest Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Harbourvest Partners LLC with notifications on news.